Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

2.

Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.

Perides G, Noring R, Klempner MS.

Biochem Biophys Res Commun. 1996 Feb 27;219(3):690-5.

PMID:
8645243
3.
4.

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi.

Klempner MS, Noring R, Epstein MP, McCloud B, Hu R, Limentani SA, Rogers RA.

J Infect Dis. 1995 May;171(5):1258-65.

PMID:
7751701
5.

The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.

Naruse K, Lash GE, Bulmer JN, Innes BA, Otun HA, Searle RF, Robson SC.

Placenta. 2009 May;30(5):398-404. doi: 10.1016/j.placenta.2009.02.002.

PMID:
19272641
6.

The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.

Hovius JW, Bijlsma MF, van der Windt GJ, Wiersinga WJ, Boukens BJ, Coumou J, Oei A, de Beer R, de Vos AF, van 't Veer C, van Dam AP, Wang P, Fikrig E, Levi MM, Roelofs JJ, van der Poll T.

PLoS Pathog. 2009 May;5(5):e1000447. doi: 10.1371/journal.ppat.1000447.

7.

Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.

Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S.

Cancer Res. 2007 Jan 1;67(1):9-15.

8.
9.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
10.

Topological localization of plasminogen activator inhibitor type 2.

Liew MA, McPhun V, Baker MS.

Cytometry. 2000 May 1;40(1):32-41.

PMID:
10754515
11.
12.
13.

Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.

Skeldal S, Larsen JV, Pedersen KE, Petersen HH, Egelund R, Christensen A, Jensen JK, Gliemann J, Andreasen PA.

FEBS J. 2006 Nov;273(22):5143-59.

15.

Plasminogen activator system in oral squamous cell carcinoma.

Baker EA, Leaper DJ, Hayter JP, Dickenson AJ.

Br J Oral Maxillofac Surg. 2007 Dec;45(8):623-7.

PMID:
17590247
16.

Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species.

Klempner MS, Noring R, Epstein MP, McCloud B, Rogers RA.

J Infect Dis. 1996 Jul;174(1):97-104.

PMID:
8656020
17.

Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes.

Fuchs H, Simon MM, Wallich R, Bechtel M, Kramer MD.

Infect Immun. 1996 Oct;64(10):4307-12.

19.

Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.

Xue A, Xue M, Jackson C, Smith RC.

Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1731-8. doi: 10.1016/j.biocel.2009.03.004.

PMID:
19433314
20.

Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.

Coolman M, de Groot CJ, Steegers EA, Geurts-Moespot A, Thomas CM, Steegers-Theunissen RP, Sweep FC.

Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):22-8.

PMID:
16584829

Supplemental Content

Support Center